Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Recruiting
N/A
Interventional Study
Lymphedema Arm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 136 (estimated)
- Sponsor
- Dharmais National Cancer Center Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Breast cancer patients aged ≥ 18 years with an ECOG score \> 1
* Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema.
* Those who have never undergone lymphedema physiotherapy.
Exclusion Criteria:
* Patients with dermal bac…
Contacts